Literature DB >> 2223305

Abnormal diastolic function in patients with type 1 diabetes and early nephropathy.

M J Sampson1, J B Chambers, D C Sprigings, P L Drury.   

Abstract

Left ventricular diastolic function was assessed by pulsed Doppler echocardiography in non-diabetic controls (n = 11) and in patients with type 1 diabetes without microvascular disease (n = 16; diabetic controls), with microalbuminuria (n = 9), or with early persistent proteinuria (n = 11). The peak filling velocities during the early and atrial phases of left ventricular diastole and their ratio (E:A ratio) were measured. All patients with diabetes had a normal serum concentration of creatinine and exercise electrocardiogram. The mean E:A ratio was significantly lower in those with proteinuria than in the diabetic controls because of an increase in peak atrial filling velocity; most patients with proteinuria had an abnormal E:A ratio of less than 1.0. Multiple regression analysis showed that systolic blood pressure was the major determinant of both the peak filling velocity during the atrial phase of diastole and also left ventricular mass. Blood pressures were significantly higher in the proteinuria group than in the diabetic controls. Glycaemic control and autonomic function did not influence diastolic filling. The slightly raised blood pressures at the earliest stages of diabetic nephropathy are sufficient to alter left ventricular diastolic compliance--this may reflect early hypertensive heart disease. These data do not preclude a specific heart muscle disease related to diabetes, but suggest that these slightly raised blood pressures contribute significantly to left ventricular dysfunction in these patients, in whom the risk of cardiovascular disease is already greatly increased.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223305      PMCID: PMC1024418          DOI: 10.1136/hrt.64.4.266

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  45 in total

1.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

2.  Diabetic cardiomyopathy.

Authors:  R I Hamby; S Zoneraich; L Sherman
Journal:  JAMA       Date:  1974-09-23       Impact factor: 56.272

3.  Mechanical and biochemical correlates of cardiac hypertrophy.

Authors:  N R Alpert; B B Hamrell; W Halpern
Journal:  Circ Res       Date:  1974-08       Impact factor: 17.367

4.  Hypertension, hypertrophy and dilatation.

Authors:  E G Olsen
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

5.  Mechanical properties of rat cardiac muscle during experimental hypertrophy.

Authors:  O H Bing; S Matsushita; B L Fanburg; H J Levine
Journal:  Circ Res       Date:  1971-02       Impact factor: 17.367

6.  Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation.

Authors:  R A Bruce
Journal:  Ann Clin Res       Date:  1971-12

Review 7.  Diastolic properties of the left ventricle.

Authors:  W Grossman; L P McLaurin
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

8.  Treadmill stress tests as indicators of presence and severity of coronary artery disease.

Authors:  N Goldschlager; A Selzer; K Cohn
Journal:  Ann Intern Med       Date:  1976-09       Impact factor: 25.391

9.  Diabetic cardiomyopathy? An echocardiographic study of young diabetics.

Authors:  J E Sanderson; D J Brown; A Rivellese; E Kohner
Journal:  Br Med J       Date:  1978-02-18

10.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

View more
  1 in total

Review 1.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.